Preeclampsia: Maternal Systemic Vascular Disorder Caused by Generalized Endothelial Dysfunction Due to Placental Antiangiogenic Factors

被引:178
作者
Tomimatsu, Takuji [1 ]
Mimura, Kazuya [1 ]
Matsuzaki, Shinya [1 ]
Endo, Masayuki [1 ]
Kumasawa, Keiichi [2 ]
Kimura, Tadashi [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, Suita, Osaka 5650871, Japan
[2] Univ Tokyo, Dept Obstet & Gynecol, Grad Sch Med, Tokyo 1130033, Japan
关键词
preeclampsia; endothelial dysfunction; angiogenic imbalance; systemic vascular dysfunction; arterial stiffness; vascular endothelial growth factor; placental growth factor; soluble fms-like tyrosine kinase 1; LOW-DOSE ASPIRIN; INTRAUTERINE GROWTH RESTRICTION; CIRCULATING ANGIOGENIC FACTORS; MOLECULAR-WEIGHT HEPARIN; 11-13 WEEKS GESTATION; PULSE-WAVE VELOCITY; TYROSINE KINASE 1; BLOOD-PRESSURE; NORMAL-PREGNANCY; NITRIC-OXIDE;
D O I
10.3390/ijms20174246
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Preeclampsia, a systemic vascular disorder characterized by new-onset hypertension and proteinuria after 20 weeks of gestation, is the leading cause of maternal and perinatal morbidity and mortality. Maternal endothelial dysfunction caused by placental factors has long been accepted with respect to the pathophysiology of preeclampsia. Over the past decade, increased production of placental antiangiogenic factors has been identified as a placental factor leading to maternal endothelial dysfunction and systemic vascular dysfunction. This review summarizes the recent advances in understanding the molecular mechanisms of endothelial dysfunction caused by placental antiangiogenic factors, and the novel clinical strategies based on these discoveries.
引用
收藏
页数:18
相关论文
共 162 条
  • [1] Association between angiogenic factors and signs of arterial aging in women with pre-eclampsia
    Akhter, T.
    Wikstrom, A. -K.
    Larsson, M.
    Larsson, A.
    Wikstrom, G.
    Naessen, T.
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2017, 50 (01) : 93 - 99
  • [2] [Anonymous], HYPERTENSION PREGNAN
  • [3] Asmar R., 1999, Arterial Stiffness and Pulse Wave Velocity, P25
  • [4] Circulating angiogenic proteins in trisomy 13
    Bdolah, Y
    Palomaki, GE
    Yaron, Y
    Bdolah-Abram, T
    Goldman, M
    Levine, RJ
    Sachs, BP
    Haddow, JE
    Karumanchi, SA
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 194 (01) : 239 - 245
  • [5] PREVENTION OF PRE-ECLAMPSIA BY EARLY ANTIPLATELET THERAPY
    BEAUFILS, M
    DONSIMONI, R
    UZAN, S
    COLAU, JC
    [J]. LANCET, 1985, 1 (8433) : 840 - 842
  • [6] Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis
    Bellamy, Leanne
    Casas, Juan-Pablo
    Hingorani, Aroon D.
    Williams, David J.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2007, 335 (7627): : 974 - 977
  • [7] BEROYZ G, 1994, LANCET, V343, P619
  • [8] Vascular endothelial growth factor up-regulates nitric oxide synthase expression in endothelial cells
    Bouloumié, A
    Schini-Kerth, VB
    Busse, R
    [J]. CARDIOVASCULAR RESEARCH, 1999, 41 (03) : 773 - 780
  • [9] Brosens I A, 1972, Obstet Gynecol Annu, V1, P177
  • [10] Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy A Meta-Analysis
    Bujold, Emmanuel
    Roberge, Stephanie
    Lacasse, Yves
    Bureau, Marc
    Audibert, Francois
    Marcoux, Sylvie
    Forest, Jean-Claude
    Giguere, Yves
    [J]. OBSTETRICS AND GYNECOLOGY, 2010, 116 (02) : 402 - 414